Quantcast

Latest Rhinitis Stories

2014-10-22 08:31:17

MISSISSAUGA, ON, Oct. 22, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced the results of a market study commissioned to investigate the U.S. opportunity for the Company's experimental immunotherapy product, WF10, as a treatment for patients with refractory allergic rhinitis. The study, performed by Psscion Lifesciences Consulting (Psscion), forecasts that WF10 could capture...

2014-10-17 08:25:31

-- Nuvo to Host Conference Call/Webcast at 8:30 a.m. ET -- MISSISSAUGA, ON, Oct. 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma plc (NASDAQ:HZNP) for a cash payment of US$45 million (CDN$50 million) which was payable on closing. Effective January 1, 2015, Horizon...

2014-10-14 20:23:15

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct. 14, 2014 /PRNewswire/ -- "About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients with pulmonary emphysema, bronchiectasis, and pulmonary fibrosis have been cured." http://photos.prnewswire.com/prnvar/20141014/151916 There is a Korean medicine doctor who has cured hundred thousands of lives of patients with chronic allergic conditions, only with Korean medicine. He...

2014-09-03 08:33:19

- Results Expected Q1 2015 - MISSISSAUGA, ON, Sept. 3, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed enrolment in its Phase 2 clinical trial to investigate the safety and efficacy of WF10 in patients with refractory allergic rhinitis. The Company expects the trial to be completed in late 2014 with top-line results anticipated in the first...

2014-08-19 23:14:11

From Aprilaire, the leaders in indoor air comfort: As fall approaches, try these 3 easy tips for reducing the symptoms of ragweed allergies without taking more medicine. Madsion, WI (PRWEB) August 19, 2014 In 2014, many allergy sufferers will try and meet the longer ragweed season with a new arsenal of products to relieve their sneezing, itching and coughing. And one of these wonder products won’t come from the pharmacy but the farmers market, as people turn to locally produced honey...

2014-07-24 16:26:21

No. 1 Prescribed Allergy Treatment Ingredient(1) to be Available OTC PARSIPPANY, N.J., July 24, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy treatment ingredient(1), as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies.(2) Flonase®...

2014-06-24 08:32:43

NEW YORK, June 24, 2014 /PRNewswire/ -- OCEAN® Nasal Care has been named the #1 Pharmacist Recommended Brand among Saline Nasal Moisturizers, according to a national survey released last week by Pharmacy Times and U.S. News & World Report. This marks the 18th consecutive year OCEAN® Nasal Care has been selected as the leading choice by pharmacists. The survey was conducted in early 2014 using 2,490 pharmacists to identify top recommended over-the-counter healthcare brands in...

2014-06-11 08:27:57

LONDON, June 11, 2014 /PRNewswire/ -- - TWO THIRDS OF PARENTS SAY ALLERGIES, INCLUDING HAY FEVER, ARE RUINING THEIR CHILDREN'S LIVES - A FIFTH OF ADULTS DREAD SUMMER BECAUSE OF THEIR HAY FEVER - BRITISH SUFFERERS WILL SPEND GBP384 MILLION TREATING ALLERGIES THIS YEAR ALONE[1] The true scale of the allergy epidemic is revealed in the British Airborne Allergy Report* commissioned by air purification specialists Fellowes...

2014-06-09 08:30:29

HØRSHOLM, Denmark, June 9, 2014 /PRNewswire/ -- First sublingual allergy immunotherapy tablet with robust results in allergic rhinitis and allergic asthma. Data supports European regulatory filing in 2H 2014 Today, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has presented key trial results on its new sublingual allergy immunotherapy tablet (SLIT-tablet) for house dust mite (HDM) respiratory allergic diseases at the 2014 Annual Congress of the European Academy of Allergy...

2014-05-14 16:27:54

Higher-than-Normal Pollen Counts Increase Demand for Superior Performing Nasal Breathing Relief BEVERLY, Mass., May 14, 2014 /PRNewswire/ -- Sinus Cones, the best and only nasal cones scientifically proven to maximize nasal inspiratory airflow(1,4), give nasal allergy sufferers the relief to breathe and sleep no matter how extraordinary their nasal allergy congestion. http://photos.prnewswire.com/prnvar/20140514/87465 "I love this product. I save so much on cold meds and never miss...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related